Published in Current Allergy and Asthma Reports
The recent approval of Palforzia for treatment of peanut allergy by the US Food and Drug Administration (USFDA) predicts that additional products for oral immunotherapy (OIT) are on the horizon. In this article, the authors review the legal framework by which the USFDA regulates products for OIT of food allergy and the clinical data that demonstrat...
Published in Current Allergy and Asthma Reports
BackgroundOlfactory dysfunction (OD) has been gaining recognition as a symptom of COVID-19, but its clinical utility has not been well defined.ObjectivesTo quantify the clinical utility of identifying OD in the diagnosis of COVID-19 and determine an estimate of the frequency of OD amongst these patients.MethodsPubMed was searched up to 1 August 202...
Published in Current Allergy and Asthma Reports
Purpose of ReviewCOVID-19 (coronavirus viral disease 2019), due to the novel SARS-CoV-2, may present with different types of cutaneous manifestations of varying pathophysiology. During the ongoing pandemic, publications reporting dermatologic findings in COVID-19 continue to emerge.Recent FindingsCutaneous vasculopathy and microthrombus-related cha...
Published in Current Allergy and Asthma Reports
Purpose of ReviewAlthough genetic factors clearly play a role in the development of atopic dermatitis (AD), the recent dramatic increase in the prevalence of AD in low- and middle-income countries is not consistent with only a role of genetic factors. These findings strongly suggest that environmental factors may play an important role in the patho...
Published in Current Allergy and Asthma Reports
Purpose of ReviewCoding for patient visits and monitoring via telehealth have expanded over the past years with a wide acceptance of telemedicine as a consequence of the coronavirus pandemic. Coding topics of interest to the allergist/immunologist in regard to services provided via telemedicine will be of increasing importance in the coming years.R...
Published in Current Allergy and Asthma Reports
Purpose of ReviewThe purpose of this review is to describe the determinants of satisfaction with telemedicine (TM) and how they compare with in-person visits from both the perspective of patients and of providers.Recent FindingsThe use of TM will expand only if patients and providers are at least as satisfied with it as they are with in-person visi...
Published in Current Allergy and Asthma Reports
The original version of this article contained errors in Table 3 on page 6.
Published in Current Allergy and Asthma Reports
Purpose of ReviewLung tissues are highly susceptible to airway inflammation as they are inevitably exposed to inhaled pathogens and allergens. In the lungs, clearance of infectious agents and regulation of inflammatory responses are important for the first-line defense, where surfactants play a role in host defense mechanisms. In this review, clini...
Published in Current Allergy and Asthma Reports
Purpose of ReviewIntranasal corticosteroid sprays have been available as over-the-counter (OTC) medications since 2013. As such, clinicians need to be up-to-date with the risks and the safety of INS, as patients may have concerns and detailed questions. The following is a review of the recent medical literature regarding the safety profile, adverse...
Published in Current Allergy and Asthma Reports
Purpose of the ReviewWe provide a systematic review of experimental and clinical evidences linking allergy to acute, including common cold, and chronic rhinosinusitis in children. Furthermore, we questioned if anti-allergy treatment may prevent the occurrence of rhinosinusitis or improve outcomes of its specific management.Recent FindingsAllergic r...
